quinidine has been researched along with phenylbutazone in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (66.67) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 3 (10.00) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Afzelius, L; Andersson, TB; Baroni, M; Cruciani, G; Karlén, A; Masimirembwa, CM; Mecucci, S; Zamora, I | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Milliken, JA | 1 |
| Belpaire, FM; Bogaert, MG; Mussche, MM | 1 |
| Blake, JW; Tobin, T; Valentine, R | 1 |
| Belpaire, F; Bogaert, M; De Broe, M; Mussche, M | 1 |
| Himberg, JJ; Julkunen, RJ | 1 |
| Klausner, JS; Weiss, DJ | 1 |
| Hanano, M; Iga, T; Sawada, Y; Sugiyama, Y | 1 |
| Almeyda, J; Levantine, A | 1 |
| Fischer, JT | 1 |
| Sellers, E; Weser, JK | 1 |
| Wosilait, WD | 1 |
| Seiler, K | 1 |
| Mason, RG; Read, MS; Saba, SR; Shermer, RW | 1 |
| Jacobsen, CD | 1 |
| Awalt, LF | 1 |
| Bailey, KR; Gallo, DG; Sheffner, AL | 1 |
| Awazu, S; Hayashi, M; Yokosuka, I | 1 |
| Knipping, W | 1 |
| ABELS, J; BOUMA, HG; NIEWEG, HO; SOEPARMAN, R | 1 |
| CROSBY, WH; KAUFMAN, RM | 1 |
4 review(s) available for quinidine and phenylbutazone
| Article | Year |
|---|---|
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Topics: Animals; Antipyrine; Barbiturates; Biological Availability; Chlorpromazine; Diazepam; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Pentazocine; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Propranolol; Quinidine; Rats; Species Specificity; Tissue Distribution; Tolbutamide; Valproic Acid; Warfarin | 1985 |
Drug reactions. XVI. Lichenoid drug eruptions.
Topics: Aminosalicylic Acids; Aniline Compounds; Arsphenamine; Chlorothiazide; Chlorpropamide; Dermatitis, Exfoliative; Gold; Humans; Hydrochlorothiazide; Lichen Planus; Methyldopa; Phenothiazines; Phenylbutazone; Quinacrine; Quinidine; Tetracycline; Thiazoles | 1971 |
[Drug-induced immune hemolytic anemias].
Topics: Adsorption; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antigen-Antibody Complex; Autoantibodies; Benzenesulfonates; Cell Membrane; Coombs Test; Drug-Related Side Effects and Adverse Reactions; Erythrocytes; Haptens; Humans; Methyldopa; Molecular Weight; Penicillins; Phenylbutazone; Quinidine; Surface Properties; Tranquilizing Agents | 1973 |
Drug interactions with coumarin anticoagulants. 2.
Topics: Allopurinol; Anabolic Agents; Animals; Anti-Bacterial Agents; Anticoagulants; Barbiturates; Chloral Hydrate; Chloramphenicol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coumarins; Dextrothyroxine; Diuretics; Drug Antagonism; Drug Synergism; Ethacrynic Acid; Ethanol; Glucagon; Glucocorticoids; Glutethimide; Humans; Oxyphenbutazone; Phenylbutazone; Quinidine; Quinine; Quinolines; Salicylates; Sulfinpyrazone; Sulfonamides; Thyroid Hormones; Tolbutamide | 1971 |
26 other study(ies) available for quinidine and phenylbutazone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.
Topics: Amino Acids; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P-450 CYP2C9; Enzyme Inhibitors; Models, Molecular; Molecular Conformation; Molecular Structure; Quantitative Structure-Activity Relationship | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[Principles of drug therapy. Cumulation].
Topics: Adult; Carbenoxolone; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Phenacetin; Phenylbutazone; Quinidine | 1979 |
Interactions of digitalis.
Topics: Arrhythmias, Cardiac; Barbiturates; Digitalis Glycosides; Digitoxin; Digoxin; Diuretics; Drug Interactions; Humans; Hypokalemia; Phenylbutazone; Potassium; Quinidine | 1979 |
Influence of acute renal failure on the protein binding of drugs in animals and in man.
Topics: Acute Kidney Injury; Animals; Blood Proteins; Cats; Digitoxin; Dogs; Female; Guinea Pigs; Humans; Male; Papaverine; Pharmaceutical Preparations; Phenylbutazone; Protein Binding; Quinidine; Rabbits; Rats; Species Specificity; Time Factors; Uranyl Nitrate; Urea; Warfarin | 1977 |
Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
Topics: Animals; Chloramphenicol; Drug Interactions; Female; Horses; Oxyphenbutazone; Phenylbutazone; Quinidine | 1977 |
Serum binding of quinidine in experimental acute renal failure.
Topics: Acute Kidney Injury; Animals; Binding Sites; Esophagus; Ligation; Male; Papaverine; Phenylbutazone; Protein Binding; Quinidine; Rabbits; Rats; Uranyl Nitrate; Ureter | 1977 |
Dry polyacrylamide batch method for studying drug protein binding.
Topics: Chromatography, Gel; Humans; Phenylbutazone; Protein Binding; Quinidine; Serum Albumin; Sulfadiazine; Sulfisoxazole; Warfarin | 1976 |
Drug-associated aplastic anemia in dogs: eight cases (1984-1988).
Topics: Anemia, Aplastic; Animals; Anti-Infective Agents; Antimalarials; Dog Diseases; Dogs; Drug Combinations; Estrogens; Fenbendazole; Meclofenamic Acid; Phenylbutazone; Quinidine; Retrospective Studies; Sulfadiazine; Trimethoprim | 1990 |
An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
Topics: Binding Sites; Carbenoxolone; Chlorpromazine; Chlorpropamide; Computers; Dose-Response Relationship, Drug; Humans; Iopanoic Acid; Pharmaceutical Preparations; Phenylbutazone; Protein Binding; Quinidine; Salicylates; Serum Albumin; Sulfadiazine; Tolbutamide | 1974 |
[Defect in oral anticoagulation. Etiology and explanation].
Topics: Anticoagulants; Blood Coagulation Disorders; Chloramphenicol; Coumarins; Drug Interactions; Glucagon; Humans; Models, Biological; Neomycin; Phenylbutazone; Protein Binding; Quinidine; Vitamin K | 1972 |
Apparent similarity of mechanisms of platelet adhesion and aggregation. Differentiation of these functions from clot retraction.
Topics: Amitriptyline; Aspirin; Blood Coagulation Tests; Caffeine; Chloromercuribenzoates; Chlorpromazine; Clot Retraction; Cocaine; Diphenhydramine; Ethacrynic Acid; Guanidines; Humans; Phenothiazines; Phentolamine; Phenylbutazone; Platelet Adhesiveness; Promethazine; Quinacrine; Quinidine; Reserpine; Sulfinpyrazone; Sulfones; Tosyl Compounds | 1972 |
[Drug-induced anemias].
Topics: Adrenal Cortex Hormones; Anemia; Barbiturates; Bone Marrow; Chloramphenicol; Chlorpromazine; Dihydroxyphenylalanine; Gastrointestinal Hemorrhage; Gold; Humans; Hypoglycemic Agents; Indomethacin; Isoniazid; Nitrofurantoin; Phenacetin; Phenylbutazone; Phenytoin; Quinidine; Quinine; Salicylates; Sulfonamides | 1970 |
Effect of other drugs on oral anticoagulants.
Topics: Acetaminophen; Anticoagulants; Coumarins; Drug Antagonism; Drug Synergism; Heparin; Humans; Oxyphenbutazone; Phenylbutazone; Prothrombin Time; Quinidine; Thromboembolism; Vitamin K; Warfarin | 1969 |
The interaction between cholestyramine and drugs.
Topics: Adsorption; Animals; Aspirin; Bile Acids and Salts; Blood; Chlorothiazide; Cholestyramine Resin; Dogs; Intestinal Absorption; Nicotinic Acids; Phenobarbital; Phenylbutazone; Quinidine; Rats; Spectrophotometry; Tetracycline; Urine; Warfarin | 1965 |
Drug distribution and binding to muscle in rat.
Topics: Actins; Animals; Carrier Proteins; Cytosol; Furosemide; Male; Muscles; Myosins; Pharmaceutical Preparations; Phenylbutazone; Quinidine; Quinine; Rats; Rats, Inbred Strains; Subcellular Fractions; Tissue Distribution | 1984 |
[Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents].
Topics: Aged; Agranulocytosis; Ajmaline; Anti-Arrhythmia Agents; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Middle Aged; Phenylbutazone; Phenytoin; Procainamide; Quinidine; Risk | 1980 |
[CLINICAL STUDY ON CHANGES IN THE BLOOD CAUSED BY DRUGS].
Topics: Anemia; Anemia, Macrocytic; Anticonvulsants; Blood Platelet Disorders; Chloramphenicol; Chloroquine; Drug Hypersensitivity; Drug Therapy; Iatrogenic Disease; Phenylbutazone; Poisoning; Purpura; Purpura, Thrombocytopenic; Quinidine; Thrombocytopenia; Toxicology | 1963 |
DRUG-INDUCED THROMBOCYTOPENIA.
Topics: Acetazolamide; Anticonvulsants; Arsphenamine; Chloramphenicol; Chlorothiazide; Colchicine; Gold; Hydantoins; Hypoglycemic Agents; Meprobamate; Perchlorates; Phenothiazines; Phenylbutazone; Pyrimethamine; Quinacrine; Quinidine; Quinine; Ristocetin; Streptomycin; Sulfonamides; Thrombocytopenia; Toxicology | 1964 |